Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Venous Thromboembolism Diagnosis and Management, and Organ Transplantation Techniques and Outcomes.
Incidence of Gastrointestinal Adverse Events Following Left Hepatic Lobe Radiation Segmentectomy for the Treatment of Hepatocellular Carcinoma.
Rates of Successful Bridging or Downstaging and Safety of Segmental Radioembolization for Hepatocellular Carcinoma in Patients with Baseline Hyperbilirubinemia.
Safety and Feasibility of Yttrium-90 Radioembolization for Cirrhosis-Induced Splenomegaly and Thrombocytopenia: Results from an Investigational Device Exemption Study
<sup>90</sup>Y Radiation Segmentectomy for Curative Intent in HCC: From Art to Science.
Yttrium-90 Transarterial Radioembolization for Intrahepatic Cholangiocarcinoma: A Comprehensive Review.
Mixed-Reality Intraprocedural Guidance for Transradial Yttrium-90 Radiation Segmentectomy of Intrahepatic Cholangiocarcinoma: Initial Clinical Experience.
Yttrium-90 Radioembolization for Androgen-Independent Prostate Cancer Metastasis to the Liver.
Real-World Analysis of Multidisciplinary Roles in the Management of Hepatocellular Carcinoma: The Mayo Clinic Experience.
Baseline Hemoglobin Predicts Oncologic Outcomes in Intrahepatic Cholangiocarcinoma Treated With Yttrium-90 Radioembolisation: A Retrospective Cohort Study of 136 Patients.
Treatment of Liver Metastases from Uveal Melanoma with Percutaneous Hepatic Perfusion.
Liver Transplant using the RAPID technique in a patient with colorectal liver metastases: Case report of a first in the United States.
Radiation segmentectomy for early hepatocellular carcinoma is curative
Radiation segmentectomy for early hepatocellular carcinoma is curative
The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma.
Yttrium-90 Radiation Segmentectomy for Treatment of Neuroendocrine Liver Metastases
Recent Advances in Ablative Therapies for Hepatocellular Carcinoma.
Escalated Segmental and Modified Radiation Lobectomy Dosing for Yttrium-90 Radioembolization of Liver-Dominant Metastatic Colorectal Cancer: 10-year Outcomes.
Radiation Segmentectomy and Modified Radiation Lobectomy for Unresectable Early-Stage Intrahepatic Cholangiocarcinoma.
The Evolving Application of Radiation Segmentectomy for the Treatment of Hepatic Malignancy.
Current applications of radiomics in the assessment of tumor microenvironment of hepatocellular carcinoma.
Design and optimization of imageable microspheres for locoregional cancer therapy.
<sup>90</sup>Y-Transarterial Radioembolization Combined with Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: A Systematic Review.
Erratum for: CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment
CT/MRI LI-RADS 2024 Update: Treatment Response Assessment.
Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors
Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors.
Radiation Segmentectomy for Hepatocellular Carcinoma.
Imageable Radioembolization Microspheres for Treatment of Unresectable Hepatocellular Carcinoma: Interim Results from a First-in-Human Trial.
Integration of Ethanol and the Immune Modulator Curcumin for Immunoablation of Hepatocellular Carcinoma.
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Hepatology · Surgery →